BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Avalyn Pharma Inc.

Headquarters: Seattle, WA, United States
Year Founded: 2011
Status: Private

BioCentury | Apr 26, 2024
Finance

Venture report: Arch, Foresite $1B AI play Xaira starting with Baker lab’s de novo biologics 

Plus rounds for Rubedo, Flindr, Endeavor, SynOx and more
BioCentury | Dec 16, 2023
Management Tracks

Mistras, Martin join Viatris

Plus: Nassim Usman at the helm at Totus as it raises $66M series B round, and updates from Tourmaline, HKEX, CIRM, CorMedix and RiverVest
BioCentury | Nov 7, 2023
Management Tracks

Krishnan promoted to president and head of R&D at OncoNano

Plus: McCourt becomes co-CEO of Hudson, and updates from MeMed, Enhance3D and Avalyn
BioCentury | Sep 28, 2023
Deals

Sept. 27 Quick Takes: Roche and Ionis taking another approach to Huntington disease

Plus: Venture financings for Avalyn, Sitryx and Singaporean newco Automera and updates from Biohaven, Ginkgo, Pfizer, Gilead and Gracell
BioCentury | Aug 7, 2023
Management Tracks

Khoo Shih named CEO of Singapore’s ClavystBio

Plus: New CEOs named at Vivoryon and Kytopen, and updates from Avalyn, Ankyra, Indaptus and more 
BioCentury | Oct 17, 2022
Management Tracks

Baranowski becomes CEO at Avalyn

Plus new CMO at Ankyra as Kaufman becomes CEO, and updates from Verge, Zentalis, Aviceda and more
BioCentury | Oct 21, 2021
Management Tracks

Dana-Farber’s David Livingston dies at 80

Plus: Alzheimer's Association, Aerie, Elevation, BioPorto, Opus and more
BioCentury | May 19, 2017
Finance

Breathe in, cash out

How a new CEO and a big series A could take Genoa to value inflection
BioCentury | May 17, 2017
Financial News

Genoa's series A brings in $62M

Items per page:
1 - 10 of 11